Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00760708 · ClinicalTrials.gov registry record
Circulating Adenosine Levels Before and After Intravenous (IV) Persantine
A clinical trial, sponsored by UConn Health.
- Terminated
- Registry status
- 221
- Enrollment target
NCT00760708 is a clinical trial that was terminated before completion, run by UConn Health. The registered enrollment target is 221 participants.
The verdict
NCT00760708 was terminated before completion, sponsored by UConn Health.
- TERMINATED
- Registry status
- 221 participants
- Enrollment target
Study Summary
Persantine is a drug that is routinely used to determine blood flow to the heart in the diagnosis of coronary heart disease. Persantine causes an increase in the adenosine level in the blood. Adenosine is a naturally occurring substance in the body that can increase blood flow. Adenosine is normally removed from the bloodstream by an adenosine transporter, which is a protein that takes up adenosine from the blood into cells. The increase in adenosine levels in the blood is variable, and the cause for this variability is unknown. A mutation for this transporter gene may contribute to this variability, and may alter its function. Thus, the purpose of this study is to determine the relationship between the mutation and the transporter function.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221 participants |
| Start Date | 2005-09 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00760708
The ClinicalTrials.gov registry entry for NCT00760708 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 221 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00760708 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00760708 about?
NCT00760708 is a clinical study titled "Circulating Adenosine Levels Before and After Intravenous (IV) Persantine". Persantine is a drug that is routinely used to determine blood flow to the heart in the diagnosis of coronary heart disease. Persantine causes an increase in the adenosine level in the blood. Adenosine is a naturally occurring substance in the body that can increase blood flow. Adenosine is normally...
What is the current status of trial NCT00760708?
This trial is currently terminated. The enrollment target is 221 participants. The study started on 2005-09. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT00760708?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.